(lp0
S"Galectin Therapeutics Reports Fourth Quarter and Full Year 2016 Financial ... Nasdaq - Mar 21, 2017 NORCROSS, Ga., March 21, 2017  -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, announced today that the Company will release fourth quarter and full year 2016&nbsp;...Analyst Observation On 2 Stocks: Curis, Inc. , Galectin Therapeutics ... - Post AnalystImportant Detailed Discussion about Galectin Therapeutics, Inc.'s  stock ... - Hot Stocks Point"
p1
aS'Galectin Therapeutics to Present at BIO CEO &amp; Investor Conference GlobeNewswire  - Feb 8, 2017 NORCROSS, Ga., Feb. 08, 2017  -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, today announced that Harold Shlevin, Ph.Small Cap Galectin Therapeutics is Sending Bullish Messages - SmallCap Networkanalysts Recommendations: Galectin Therapeutics, Inc.  - News Oracle'
p2
aS'Galectin Therapeutics to Present at 29th Annual ROTH Conference GlobeNewswire  - Mar 9, 2017 NORCROSS, Ga., March 09, 2017  -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, today announced that Harold Shlevin, Ph.The Analysts Anticipate Galectin Therapeutics Inc  to Post ($0.17 ... - DailyQuint'
p3
aS"Why Galectin Therapeutics Just Lost Nearly Half Its Market Cap Benzinga - Sep 28, 2016 Shares of Galectin Therapeutics Inc , a clinical-stage biopharmaceutical company that creates therapies for fibrotic disease and cancer, tumbled nearly 50 percent on Wednesday after the company said that a Phase 2a study called NASH-FX&nbsp;...Galectin Therapeutics Announces Top-Line Data from Exploratory Phase 2a Pilot ... - GlobeNewswire Stock Update : Here's Why Galectin Therapeutics Inc Shares Are ... - Smarter Analyst"
p4
aS'Galectin Therapeutics Inc  Runs Higher 7.49% For the Week Business Review - 11 hours ago Over the past five sessions, Galectin Therapeutics Inc  has pulled in nice gains, moving higher 7.49% over the past five sessions.'
p5
aS'Galectin Therapeutics Inc  Is An Alternative Catalyst Play Insider Financial - Feb 16, 2017 Galectin Therapeutics Inc  is drawing some considerable volume at the moment, and the company is up more than 45% this week alone as a result.Trading Covered Calls: Galectin Therapeutics Inc  : A Clever ... - CML News'
p6
aS'A Major Catalyst Awaits Galectin Therapeutics Next Week Seeking Alpha - Sep 23, 2016 Galectin Therapeutics  is a micro biotechnology company  focused on targeting galectin proteins.Two Speculative NASH Allocations Post Allergan plc Ordinary Shares (NYSE:AGN ... - Market Exclusive'
p7
aS'Galectin Therapeutics Announces Achievement of Key Milestones Related to NASH ... GlobeNewswire  - Feb 1, 2017 NORCROSS, Ga., Feb. 01, 2017  -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, today announced it has generated sufficient financing to cover currently planned&nbsp;...'
p8
aS'Galectin Therapeutics Announces $4 Million in New Equity Financings GlobeNewswire  - Dec 29, 2016 NORCROSS, Ga., Dec. 29, 2016  -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, today announced it has recently completed a private placement of its common stock,&nbsp;...GALECTIN THERAPEUTICS INC.  Files An 8-K Entry into a Material ... - Market Exclusive'
p9
aS'16 hedge funds sold their entire positions in Galectin Therapeutics, Inc ... Post Analyst - 15 hours ago Galectin Therapeutics, Inc.  reached 310.2% versus a 1-year low price of $0.49. The stock was last seen -4.74% lower, reaching at $2.01 on Mar. 21, 2017.DSP Group, Inc.  Reaches $11.27 After 5.00% Down Move, Galectin ... - MoneyMakingArticles'
p10
a.